Infection and infestation-related adverse events of ocrelizumab: A disproportionality analysis using FDA adverse event reporting system
Ocrelizumab may increase the risk of many infections and infestations, including enterovirus-related central nervous system infections, tick-borne infections, COVID-19-related disorders, genital tract infections and herpes infections, and therefore requires careful monitoring in clinical practice.
Authors
- Nesrin Çağlayan Duman (ORCID: https://orcid.org/0000-0002-3215-590X)
Institutions
- Ordu University (TR)
Publication Details
- Journal
- Northern Clinics of Istanbul
- Published
- 2025-01-01
- DOI
- https://doi.org/10.14744/nci.2025.95881
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31